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abstract
Introduction: Thoracic bioimpedance is a simple, cost-effective, and non-invasive tool 
used generally to determine several hemodynamic parameters. Based on this technique, 
the cardiac output and the stroke volume are the most common parameters used for 
diagnosing heart diseases. This study aims to investigate the ability of the arterial 
compliance parameter to predict or detect the presence of heart diseases. 
Methods: two groups of young subjects participated in this study: a control group 
consisted of 10 subjects including 2 athletes and a group of 10 patients with various 
heart diseases. The thoracic bioimpedance recordings are used to determine the arterial 
compliance for the 2 groups of subjects. Statistical analyses are performed using the 
Student’s t-test and the ROC curve analysis. 
Results: Experimental results show that the arterial compliance is significantly lower in 
patients with heart diseases compared to control subjects (P < 0.001). 
Conclusions: The arterial compliance is a potentially useful hemodynamic parameter 
which could be successfully used to predict or detect the presence of heart diseases.
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Cardiovascular diseases (CVD) are the main cause of death 
in the world. The most important risk factors are hyperten-
sion, physical inactivity, smoking, unhealthy diet, high blood 
glucose, cholesterol and obesity. However, it has been report-
ed that the early detection and the treatment of CVD can 
avoid any fatal complications and can consequently reduce 
the mortality rate [1]. Therefore, several screening tools have 
been used for diagnosing CVD such as Electrocardiography 
(ECG), Doppler Echocardiography, magnetic resonance im-
aging (MRI), chest X-ray, and etc. Biomedical researchers 
and scientists have always tried to find and develop the most 
effective and the easiest diagnostic tool. Particularly, thoracic 
bioimpedance is one of the screening techniques which are 
still under development. In fact, thoracic bioimpedance is a 
simple, non-invasive and cost-effective tool for monitoring 
electrical impedance changes in the thorax [2]. It has been 
used to compute various hemodynamic parameters such as 
cardiac output (CO), stroke volume (SV), left ventricular 
ejection time (LVET), arterial compliance, and etc. Based 
on these derived parameters, mainly the CO and the SV, bio-
impedance has been widely used for diagnosing several heart 
diseases like mitral insufficiency [3]and myocardial infarc-
tion [4]. In this study, we proposed to use, precisely, the arte-
rial compliance parameter to predict or detect the presence of 
heart diseases. Arterial compliance has not been extensively 
used for clinical screening purpose but it has been success-
fully used in other applications. Indeed, it has been used to 
evaluate the effects of aging on the arterial blood vessels; thus 
it has been reported that after the age 50 the arterial compli-
ance decreases rapidly. Furthermore, this hemodynamic pa-
rameter has been considered as a marker of arterial stiffness 
and a clinical index of the buffering function of the arterial 
system. Besides, it has been demonstrated that an abnormal-
ities in arterial compliance is associated to the presence of 
atherosclerotic plaque [5, 6]. Clinically, arterial compliance 
is defined as the change in arterial blood volume (ΔV) due to 
a given change in arterial blood pressure (ΔP). Precisely, arte-
rial compliance is described as the ratio between the volume 
variation and the pressure variation (ΔV/ΔP). Therefore, a 
high blood pressure (hypertension) can be due to a decrease 
in arterial compliance [5]. As mentioned above, hyperten-
sion has been considered as one of the most important car-
diovascular risk factor, thus according to our point of view, 
the arterial compliance can be used as a predictor of a future 
heart disease. The above theoretical estimate will be devel-
oped and discussed in this current study.
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METHODS
Study Population
For this study, inclusion criteria were as follows: (1) an age 
less than 35 years and more than 18 years, (2) patients with 
isolated heart disease (the patients who had additional dis-
eases were excluded), (3) absence of an artificial pacemak-
er, (4) male gender, (5) non-smokers population. The study 
population consisted of two groups of subjects: a control 
group of 10 subjects including 2 athletes (100% male, having 
an average age of 25.6 ± 5.17 years: ranging from 18 to 34 
years) and a group of 10 patients with various heart diseases, 
including mitral stenosis, cardiac insufficiency and myocardi-
al infarction (100% male, having an average age of 25.9 ± 4.36 
years: ranging from 21 to 32 years). 
Thoracic Bioimpedance Measurements
The thoracic bioimpedance recordings used in this study 
were obtained following the method of Ben Salah et al. [7]. 
In this method, a constant, alternating, high frequency, and 
small current (1 mA, 30 kHz) is applied, through two elec-
trodes, into the forehead and above the leading edge of the 
heart. Two other electrodes are placed between the injection 
electrodes (in the left side of the patients’ chest), at the lev-
el of aorta 2 or 3 cm apart, to measure the acquired voltage. 
During the signal recordings, the patient must lie supine, re-
laxed and in expiratory apnea for a period of 10 seconds. The 
proposed electrodes configuration is shown in Fig 1.
Figure 1: Electrodes Configuration for the Thoracic Bioimpedance 
Measurement
The bioimpedance recording represents the impedance vari-
ation of the explored thoracic region versus time samples. 
A typical thoracic bioimpedance tracing is shown in Fig 2. 
Mathematically, the impedance (Z) is defined by Ohm’s law 
as the ratio between the voltage signal measured (V) and the 
current signal injected (I). The impedance is inversely pro-
portional to the chest’s fluid content; it increases or decreases 
when the fluid falls or rises, respectively. The impedance var-
ies with tissue composition, tissue structure and tissue health 
status [8].












Figure 2: Typical Example of Thoracic Bioimpedance Tracing
The Determination of arterial Compliance
The first purpose of this current study is the determination 
of the arterial compliance using the thoracic bioimpedance 
technique. The second purpose consists to investigate the 
ability of this estimated compliance in the prediction or the 
detection of heart diseases. 
As mentioned above the arterial compliance Cp is the ratio of 
arterial blood volume ΔV to arterial blood pressure ΔP: 
Cp=∆V/∆P Eq. 1
Using the thoracic bioimpedance, the pulsatile volume 
change  is presented as follows:
∆V=(ρL2 ∆Z)/(Z0
2 ) Eq. 2
Where: 
ρ: is the resistivity of blood (Ω.cm).
L: is the length of the explored section (cm).
ΔZ: is the magnitude of the pulsatile impedance change 
(impedance variation).
Z0: is the impedance measured when the pulsatile volume is 
minimum (diastolic or basic impedance) (Ω).
The instantaneous aortic pressure P(t) derived from the tho-
racic bioimpedance record was determined using the mathe-
matical formula developed in [9]:
P(t)=PDia+(PSys-PDia) (Z(t))/Zmax Eq.3
Where:
PSys: presents the systolic blood pressure (mmHg). 
PDia: presents the diastolic blood pressure (mmHg).
Z(t): is the instantaneous bioimpedance signal.
Zmax : is the maximum amplitude of the thoracic bioimped-
ance record.
Consequently, the arterial compliance Cp (ml/mmHg) was 
estimated as follows [10]:
Cp=(ρL
2 Zmax)/(Z0
2 (PSys-PDia))  Eq.4
Noted that the systolic and the diastolic blood pressures (PSys 
and PDia) were non-invasively measured using an electronic 
sphygmomanometer model, MP3 FUZZY.
Throughout this study, the arterial compliance Cp is deter-
mined for 2 groups of subjects (control subjects and patients 
having various heart diseases) in order to evaluate the capac-
ity of this hemodynamic parameter (Cp) to predict or detect 
the presence of heart diseases.
Statistical analysis
In this study, data were expressed as mean ± standard devia-
tion (SD). Student’s t–test was used to evaluate the difference 
in arterial compliance values between two groups of subjects 
(control subjects and patients with various heart diseases). 
Moreover, the Receiver Operating Characteristic (ROC) 
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curve was used to evaluate the ability of the arterial compli-
ance to distinguish between control subjects and patients 
with heart diseases. The optimum cut-off, sensitivity (Se), 
specificity (Sp), negative predictive values (NPV), positive 
predictive values (PPV), and the area under the ROC curve 
(AUC) were computed. The ROC curve was generated using 
the MedCalc software, version 17.8. Besides, a p–value of less 
than 0.05 was considered statistically significant. 
RESulTS
The estimated arterial compliance values for control subjects 
and patients with various heart diseases are shown in Fig 3. 
In terms of this figure, it is clearly seen that the arterial com-
pliance is lower in patients with heart diseases (blue graph: 
from patients D1 to patients D10) compared to control sub-
jects (red graph: from subjects C1 to subjects CA10). Partic-
ularly, for control subjects, CA9 and CA10 subjects have the 
highest arterial compliance values; indeed CA9 and CA10 
correspond to 2 athlete subjects.
The mean value (± SD) of the arterial compliance for control 
subjects and patients with various heart diseases is illustrated 
in Table 1. It is vivid from this table that the arterial compli-
ance was significantly decreased in patients with heart diseas-
es compared to control subjects (2.11± 0.79 ml/mmHg for 
control subjects vs. 0.99 ± 0.14 ml/mmHg for patients with 
heart diseases). Student’s t-test demonstrates that there was 
highly significant difference between control subjects and pa-
tients with heart diseases (P < 0.001).
The ROC curve analysis results of the arterial compliance 
parameter are illustrated in Table 2. The optimum cut-off is 
lower than, or equal to, 1.18 ml/mmHg, the sensitivity, the 
specificity, the positive predictive value, and the negative pre-
dictive values are about 100%. The AUC of the ROC curve 
is equal to 1. Therefore, the obtained results demonstrate the 
high ability of the arterial compliance to distinguish between 
control subjects and patient with heart diseases (P < 0.0001). 
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Figure 3: The Estimated Arterial Compliance for Control Subjects 
(Red Graph: from Subject C1 to Subject CA10) and Patients with 
Heart Diseases (Blue Graph: from Patient D1 to Patient D10).
Figure 4: ROC Curve for the Arterial Compliance Parameter 
(AUC = 1, P < 0.0001).
Table 1: Mean Value (± SD) of the Arterial Compliance for Control Subjects and Patients with Various Heart Diseases
Hemodynamic parameter Control subjects Patients with various heart diseases t-values
Arterial Compliance (ml/mmHg) 2.11 ± 0.79 0.99 ± 0.14 4.17*
Note: * P < 0.001: The Difference is Highly Significant.
Table 2: ROC Curve Analysis of the Arterial Compliance Parameter.
Hemodynamic parameter AUC P Optimum cut-off Se (%) Sp (%) PPV (%) NPV (%)
Arterial Compliance 1 <0.0001 ≤ 1.18 ml/mmHg 100 100 100 100
Note: AUC: Area Under The ROC Curve; Se: Sensitivity; Sp: Specificity; PPV: Positive Predictive Value; NPV: Negative Predictive Value
DISCuSSION
The main purpose of this study is to investigate the ability 
of arterial compliance to predict or detect the presence of 
heart diseases. This important hemodynamic parameter is 
estimated using the thoracic bioimpedance technique which 
still under development. In order to avoid the effects of age 
in arterial compliance, we have included only young subjects. 
The high blood pressure is considered as the most important 
risk factor for cardiovascular diseases; this cause a theoretical 
falls in the atrial compliance. In this study, experimental re-
sults demonstrate that the arterial compliance is significantly 
lower in patients with heart diseases than in control subjects. 
These results present a high degree of reproducibility for all 
the study population. Therefore, we can assume that the arte-
rial compliance is a useful and efficient hemodynamic param-
eter that can be used to detect the presence of heart diseases. 
Moreover, arterial compliance can be used as a predictor of a 
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future heart disease. On the other hand, the obtained results 
also show that the arterial compliance increases in athlete 
subjects. Thus, we can report that the arterial compliance can 
distinguish between normal and athlete subjects. However, 
the lack of a “gold standard” tool for estimating arterial com-
pliance remains a major drawback in this study. Usually, the 
arterial compliance can be estimated using a variety of tech-
niques like angiography, magnetic resonance imaging, trans-
thoracic echocardiography [5], and etc. Although the accura-
cy of these techniques, they are still expensive, discontinuous 
and require high level skills. For these reasons, we suggested 
in this current study to use the thoracic bioimpedance tech-
nique which is simple, low-cost, continuous (can perform 
an ambulatory measurement) and requires less skill. In the 
future research, we will try to use another tool for the deter-
mination of arterial compliance (like the magnetic resonance 
imaging MRI) in order to perform a comparison between 
the obtained results. Moreover, a larger number of patients 
are needed in order to further quantify and recommend our 
method. Furthermore, we will investigate the ability of the 
arterial compliance parameter to distinguish between several 
heart diseases.
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